For how we live.
A CDC analysis of nearly 1.3 million overdose hospitalisations from 2016 to 2025 found acute kidney injury in 34.5% of them, and a severe inpatient course in three-fifths of those cases.
A Global Burden of Disease analysis puts substance use disorder prevalence at 0.78% across the Arab League in 2023, about 63% below the global figure — yet women's opioid prevalence topped men's in 19 of 22 countries.
The agency is describing the trial design it is weighing for ibogaine, a psychedelic with serious cardiac risks, as HHS funds the first federal studies in opioid use disorder and PTSD. Comments close 20 November.
A pandemic waiver letting clinicians prescribe stimulants and other controlled medicines without an in-person visit has been extended a fourth time, to end-2026, with the permanent framework still a proposal.
A British Columbia study emulated a trial across 41,000 patients. Those started on take-home methadone within weeks to months of induction stayed in treatment longer and died less than those on daily witnessed dosing.
A review lays out the evidence chain: animal studies showing reduced drug-seeking, one small human trial, and record-based analyses linking GLP-1 prescriptions to 40% fewer opioid overdoses.